Cargando…
First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using (68)Ga-IRDye800CW-BBN
Purpose: Despite the use of fluorescence-guided surgery (FGS), maximum safe resection of glioblastoma multiforme (GBM) remains a major challenge. It has restricted surgeons between preoperative diagnosis and intraoperative treatment. Currently, an integrated approach combining preoperative assessmen...
Autores principales: | Li, Deling, Zhang, Jingjing, Chi, Chongwei, Xiao, Xiong, Wang, Junmei, Lang, Lixin, Ali, Iqbal, Niu, Gang, Zhang, Liwei, Tian, Jie, Ji, Nan, Zhu, Zhaohui, Chen, Xiaoyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928906/ https://www.ncbi.nlm.nih.gov/pubmed/29721096 http://dx.doi.org/10.7150/thno.25599 |
Ejemplares similares
-
Resection and survival data from a clinical trial of glioblastoma multiforme‐specific IRDye800‐BBN fluorescence‐guided surgery
por: He, Kunshan, et al.
Publicado: (2020) -
Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers
por: Gao, Rebecca W., et al.
Publicado: (2018) -
Near-Infrared Fluorescence Imaging of EGFR-Overexpressing Tumors in the Mouse Xenograft Model Using scFv-IRDye800CW and Cetuximab-IRDye800CW
por: Amini, Abolfazl, et al.
Publicado: (2022) -
In Vivo Evaluation of Gallium-68-Labeled IRDye800CW as a Necrosis Avid Contrast Agent in Solid Tumors
por: Stroet, Marcus C. M., et al.
Publicado: (2021) -
Preclinical assessment of IRDye800CW‐labeled gastrin‐releasing peptide receptor‐targeting peptide for near infrared‐II imaging of brain malignancies
por: Zhang, Yuan, et al.
Publicado: (2023)